Clinical Trial: An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: An Epidemiological Study Aimed to Record Standard Daily Practice in Managing Patients With Hypercholesterolemia

Brief Summary: This study is aimed to collect the following Serbia-specific epidemiology data on hypercholesterolemia: patents characteristics, patients' management/treatment and physicians' standard practice. In addition, the aim is to determine the proportion of patients on lipid-lowering pharmacological treatment who have reached the LDL-C and HDL-C treatment goals.

Detailed Summary:
Sponsor: AstraZeneca

Current Primary Outcome: Proportion of patients on lipid-lowering pharmacological treatment reaching the LDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines [ Time Frame: 24 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • Proportion of patients on lipid-lowering pharmacological treatment reaching the non HDL-C goals according to the NCEP ATP III / updated 2004 NCEP ATP III guidelines; [ Time Frame: 24 weeks ]
  • Physicians' standard practice in managing patients with hypercholesterolemia (by using physicians' questionnaire); [ Time Frame: 24 weeks ]
  • Local epidemiological date on patients with hypercholesterolemia (Demographic Data; Hypercholesterolemia management data: treatment, treatment changes) [ Time Frame: 24 weeks ]


Original Secondary Outcome: Same as current

Information By: AstraZeneca

Dates:
Date Received: September 20, 2010
Date Started: December 2010
Date Completion:
Last Updated: November 7, 2011
Last Verified: November 2011